Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis
-
Published:2023-12
Issue:
Volume:
Page:
-
ISSN:0923-7534
-
Container-title:Annals of Oncology
-
language:en
-
Short-container-title:Annals of Oncology
Author:
Piulats J.M.ORCID,
Watkins C.,
Costa-García M.,
del Carpio L.,
Piperno-Neumann S.,
Rutkowski P.,
Hassel J.C.,
Espinosa E.,
de la Cruz-Merino L.,
Ochsenreither S.,
Shoushtari A.N.,
Orloff M.,
Salama A.K.S.,
Goodall H.M.,
Baurain J.-F.,
Nathan P.ORCID
Subject
Oncology,Hematology
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献